Patient registries may prove valuable in regulatory decisions, EMA study finds
Although patient registries can be heterogeneous in their quality and design, a new study in Drug Safety co-authored by an EMA official explains how patient …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
